The evidence is solid but not definitive, as the conclusions rely on the absence of changes in spatial breadth and would benefit from clearer statistical justification and a more cautious ...

Acadia Healthcare has a rare setup of deep value, steady cash flows, and oversized selling by bearish short players. Click ...

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company ...

This study presents a potentially valuable exploration of the role of thalamic nuclei in language processing. The results will be of interest to researchers interested in the neurobiology of language.

GLP-1 drugs have ushered in a new era in weight loss. But success brings a new question that millions of Americans are now ...

Good morning, and welcome to Enel Capital Market Day 2026. Thank you, everyone here in the room and to people connected online. I'm here today with Enel's CEO, Mr. Flavio Cattaneo; and CFO, Mr.

“The Nefertiti lift has made a comeback,” says Ahluwalia. It’s a technique where neurotoxin is injected in the platysma, the ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

Two iconic Boeing aircraft that have a lot in common, but also, plenty of interesting differences. What really makes these aircraft unique?

John Flanagan, PhD, discusses his team's study that shows that a high-protein, low-digestible-carbohydrate diet combined with controlled weight loss may improve diabetic remission rates in overweight ...

John Flanagan, PhD, presented new research at WVC 2026 that shows that a purpose-formulated, low-digestible carbohydrate diet combined with structured caloric restriction substantially increases short ...